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Abstract: Background Tissue microarray (TMA) technology revolutionized the investigation of potential
biomarkers from paraffin-embedded tissues. However, conventional TMA construction is laborious, time-
consuming and imprecise. Next-generation tissue microarrays (ngTMA) combine histological expertise
with digital pathology and automated tissue microarraying. The aim of this study was to test the
feasibility of ngTMA for the investigation of biomarkers within the tumor microenvironment (tumor
center and invasion front) of six tumor types, using CD3, CD8 and CD45RO as an example. Methods Ten
cases each of malignant melanoma, lung, breast, gastric, prostate and colorectal cancers were reviewed.
The most representative HE slide was scanned and uploaded onto a digital slide management platform.
Slides were viewed and seven TMA annotations of 1 mm in diameter were placed directly onto the digital
slide. Different colors were used to identify the exact regions in normal tissue (n = 1), tumor center
(n = 2), tumor front (n = 2), and tumor microenvironment at invasion front (n = 2) for subsequent
punching. Donor blocks were loaded into an automated tissue microarrayer. Images of the donor block
were superimposed with annotated digital slides. Exact annotated regions were punched out of each donor
block and transferred into a TMA block. 420 tissue cores created two ngTMA blocks. HE staining and
immunohistochemistry for CD3, CD8 and CD45RO were performed. Results All 60 slides were scanned
automatically (total time < 10 hours), uploaded and viewed. Annotation time was 1 hour. The 60 donor
blocks were loaded into the tissue microarrayer, simultaneously. Alignment of donor block images and
digital slides was possible in less than 2 minutes/case. Automated punching of tissue cores and transfer
took 12 seconds/core. Total ngTMA construction time was 1.4 hours. Stains for HE and CD3, CD8 and
CD45RO highlighted the precision with which ngTMA could capture regions of tumor-stroma interaction
of each cancer and the T-lymphocytic immune reaction within the tumor microenvironment. Conclusion
Based on a manual selection criteria, ngTMA is able to precisely capture histological zones or cell types
of interest in a precise and accurate way, aiding the pathological study of the tumor microenvironment.
This approach would be advantageous for visualizing proteins, DNA, mRNA and microRNAs in specific
cell types using in situ hybridization techniques.
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tumor microenvironment of six different solid
tumor types
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Abstract
Background: Tissue microarray (TMA) technology revolutionized the investigation of potential biomarkers from
paraffin-embedded tissues. However, conventional TMA construction is laborious, time-consuming and imprecise.
Next-generation tissue microarrays (ngTMA) combine histological expertise with digital pathology and automated
tissue microarraying. The aim of this study was to test the feasibility of ngTMA for the investigation of biomarkers
within the tumor microenvironment (tumor center and invasion front) of six tumor types, using CD3, CD8 and
CD45RO as an example.
Methods: Ten cases each of malignant melanoma, lung, breast, gastric, prostate and colorectal cancers were
reviewed. The most representative H&E slide was scanned and uploaded onto a digital slide management platform.
Slides were viewed and seven TMA annotations of 1 mm in diameter were placed directly onto the digital slide.
Different colors were used to identify the exact regions in normal tissue (n = 1), tumor center (n = 2), tumor front
(n = 2), and tumor microenvironment at invasion front (n = 2) for subsequent punching. Donor blocks were loaded
into an automated tissue microarrayer. Images of the donor block were superimposed with annotated digital slides.
Exact annotated regions were punched out of each donor block and transferred into a TMA block. 420 tissue cores
created two ngTMA blocks. H&E staining and immunohistochemistry for CD3, CD8 and CD45RO were performed.
Results: All 60 slides were scanned automatically (total time < 10 hours), uploaded and viewed. Annotation time
was 1 hour. The 60 donor blocks were loaded into the tissue microarrayer, simultaneously. Alignment of donor
block images and digital slides was possible in less than 2 minutes/case. Automated punching of tissue cores and
transfer took 12 seconds/core. Total ngTMA construction time was 1.4 hours. Stains for H&E and CD3, CD8 and
CD45RO highlighted the precision with which ngTMA could capture regions of tumor-stroma interaction of each
cancer and the T-lymphocytic immune reaction within the tumor microenvironment.
Conclusion: Based on a manual selection criteria, ngTMA is able to precisely capture histological zones or cell types
of interest in a precise and accurate way, aiding the pathological study of the tumor microenvironment. This
approach would be advantageous for visualizing proteins, DNA, mRNA and microRNAs in specific cell types using in
situ hybridization techniques.
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Introduction
In the late 1990s, tissue microarray (TMA) technology
revolutionized the investigation of potential prognostic
and predictive biomarkers [1]. TMAs involve the trans-
fer of small tissue cores, typically 0.6 mm in diameter,
from formalin-fixed paraffin-embedded (FFPE) tissues
into an empty paraffin block [2]. This repeated transfer
of tissue cores leads to the construction of a “tissue-
archive” that can contain hundreds of tissue samples
from a small or large number of patients. TMAs can be
used to study tissue morphology, expression of proteins
or genes and chromosomal aberrations using different
stains, immunohistochemistry and in situ hybridization
[3-5]. The combination of TMAs and clinically anno-
tated samples represents an elegant and cost-effective
approach to study panels of biomarkers under identical
experimental conditions and to develop prognostic or
predictive models of patient outcomes [6].
Figure 1 Two examples showing scanned H&E sections, followed by annotations of specific histological regions and high-power
magnifications of two different annotated regions. A-D: malignant melanoma; E-H: colorectal cancer. Yellow annotation: tumor center, blue:
tumor microenvironment at most invasive tumor front, red: invasion front, green: normal tissue. 5× magnification.
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Despite these considerable advantages, conventional
construction of TMAs is not without its limitations.
TMA construction is often described as a meticulous,
laborious and time-consuming process. A major drawback
lies in the “approximation” of desired tissue spots for
transfer into the TMA. Before tissues can be punched out
of their blocks, the corresponding hematoxylin and eosin
(H&E) slides are reviewed. The histological areas of inter-
est are then marked using a felt-tip pen directly on the
slide. When various tissue types are present, different
colors and marking of assorted sizes are made. Patholo-
gists familiar with TMA construction will confirm that
annotating “specific” regions of interest in this manner is
challenging. The manual alignment of the annotated
region from an H&E slide to the donating block is not
always exact.
It is now recognized that tumor heterogeneity can
have a significant impact on the interpretation of
biomarkers [7]. Increasingly important is the targeting of
particular cell types, tissue types or histological zones
using various core diameters of 0.6, 1.0, 1.5 or 2.0 mm.
Traditional methods of tissue microarraying are subopti-
mal to achieve this goal; there is hence an urgent need
to improve TMA technology to acquire histological
precision, enhance the accuracy of punching and speed
of construction. We have used the term next-generation
TMAs (ngTMAs) to define the combination of cutting-
edge digital pathology, automated tissue microarraying
and histopathological expertise. The goal is to create
TMAs containing the accurately determined histological
structures with the aim of further optimizing biomarker
research.
An example where ngTMAs would be useful is the
investigation of the immune infiltrates in patients with
different tumor types [8]. In colorectal cancers, immuno-
histochemical panels of immune infiltrates such as CD3,
CD8 and CD45RO have been investigated in the tumor
microenvironment within the main tumor body as well as
at the invasion front.
The aim of this study was to determine the feasibility
of ngTMAs to investigate biomarkers at the tumor-stroma
interface within the main tumor body and invasion front
of six tumor types: malignant melanomas, as well as lung,
prostate, gastric, colon and breast cancers, using T-cell
markers CD3, CD8 and CD45RO as an example.
Materials and methods
Case selection
In order to investigate the feasibility of ngTMAs for the
assessment of host-related factors of the tumor micro-
environment, six of the most frequently diagnosed tumor
types were selected. Sixty cases were retrieved from the
archives of the Institute of Pathology, University of Bern
from 2009–2011 including 10 cases each of lung cancer,
breast cancer, prostate cancer, gastric cancer, malignant
melanoma and colon cancer. The diagnostic H&E slides
were reviewed and the most representative one con-
cerning the tumor microenvironment was selected for
Figure 2 Representative H&E stains of ngTMA tissue spots. A) lung cancer, B) breast cancer, C) prostate cancer, D) gastric cancer, E) malignant
melanoma and F) colorectal cancer; 10× magnification.
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subsequent scanning. The use of patient material has been
approved by the ethics committee of the Bern University
Hospital (16-03-12).
Slide scanning and annotation
The selected H&E slide of each whole tissue section was
placed into a scanning cartridge and loaded into the
slide scanner (Pannoramic P250, 3DHistech). All 60 slides
could be processed in a single run. Digital images were
uploaded onto the digital slide management platform Case
Center (http://ngtma.path.unibe.ch/casecenter). Each slide
could then be opened and viewed using Pannoramic
Viewer software (3DHistech).
Using the 1.0 mm annotation tool, annotations of dif-
ferent colors corresponding to various histological areas
were placed onto each digital slide. Although other sizes
were available (0.6, 1.5 and 2.0 mm diameter annotation
tools), we opted for 1.0 mm annotations for several rea-
sons. Firstly, we wanted to capture large enough regions
containing both tumor and stroma. Secondly, because of
the potential heterogeneity of the tumor sample, several
different tissue spots would need to be included. Thirdly,
at least 1 normal tissue core per case would be necessary
to provide a “control” for comparing staining patterns in
tumors for different proteins or genes via immunostain-
ing and fourthly, using 1 mm cores still leads to a mini-
mum number of ngTMAs to be constructed. One green
Figure 3 Representative immunohistochemistry staining for CD3, CD8 and CD45RO and each cancer type; 5× magnification.
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annotation was placed on normal tissue, two yellow
annotations on the tumor center, two red annotations for
the tumor periphery or invasion front and two blue anno-
tations were used to capture areas of tumor budding and
surrounding stroma (i.e., tumor microenvironment at the
invasion front) (Figure 1). In total, 7 tissue spots were
annotated per case, totaling 420 spots for subsequent
punching and tissue microarraying.
Automated tissue microarraying
The 60 donor blocks corresponding to the 60 annotated
digital slides were loaded into the automated tissue
microarrayer (Grandmaster, 3DHistech) and an image of
each block was taken. Two empty paraffin embedded
recipient blocks were simultaneously loaded. A tissue
microarray layout was created to design a punching-
schema for the final tissue microarray block. The created
layout consisted of 243 tissue punches at 1 mm in
diameter, suggesting that 2 ngTMA blocks would be
sufficient for this study.
With the Grandmaster software, each digital slide could
be retrieved from the Case Center. Using tissue landmarks,
the image of the donor block and the digital slide were
superimposed for exact correspondence. Annotations could
then be viewed and confirmed. Punching of the donor
blocks and transfer into the recipient block could be made
after confirmation of each annotation and occurred in the
sequence arranged with the layout. The result was 2
ngTMAs, the first containing tissue cores of lung, stomach,
colon and breast and the second containing additional
spots of breast, malignant melanoma and prostate tissues.
Immunohistochemistry
The two ngTMAs were sectioned at 4 μm. After de-
paraffination and rehydration, standard H&E staining
was undertaken. In order to visualize the host-related
immune markers, immunohistochemistry for the follow-
ing antibodies was performed using an automated
immunostainer (Leica, Bond III): Anti-CD3 (Abcam, clone
SP7, tris buffer, 95° 30 minutes, 1:400), anti-CD8 (Dako,
clone C8/144B, Tris buffer, 95° 20 minutes, 1:100) and
anti-CD45RO (Abcam, clone UCH-L1, citrate buffer, 100°
30 minutes, 1:4000).
Results
Slide scanning and annotation
All 60 slides could be loaded and scanned automatically
overnight. The time required for each scan varied in
accordance with the size of the whole tissue section and
ranged from 5 to 12 minutes. Total scanning time was
approximately 10 hours. Slides were directly uploaded to
the correct folder in the Case Center. Digital slide anno-
tation could be easily and rapidly performed in 1 minute,
on average. Therefore, 7 annotations on 60 cases could
be performed within 1 hour.
Automated tissue microarraying
The maximum capacity of the Grandmaster arrayer is 60
donor blocks therefore all selected blocks could be
uploaded simultaneously. Land marking of donor block
images and correspondence with digital slides was
possible in less than 2 minutes per case followed by
confirmation of annotated regions. Automated punching
of tissue cores and transfer to the recipient block took
12 second per core. Punching could either be performed
after confirming all annotations or after each single
confirmed annotation. Total time for creating the 2
Figure 4 The ngTMA process: strategic and operative levels.
The first step in the construction of ngTMAs is the design and
planning in terms of the scientific hypothesis, available material, case
selection, as well as TMA and statistical considerations. The operative
level begins by slide scanning and the use of a digital platform.
Histological expertise is necessary to perform precise annotations.
Automated tissue microarraying ensues. The final product is an
optimized ngTMA which will allow the user to answer the
hypothesis in question.
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ngTMAs containing 420 cores at 1 mm in diameter was
1.4 hours.
Less than 2% of all tissue cores were unsuccessfully
transferred from the donor block to the recipient block.
These cores could however be recuperated in a second
attempt resulting in a 100% successful transfer rate.
The tumor microenvironment is captured using ngTMA
In Figure 2, representative images of H&E stained spots
from the two ngTMAs containing each of the 6 tissue
types of interest are shown. These outline the precision
with which ngTMA could capture regions of tumor-
stroma interaction at the invasion front of each cancer.
Evaluation of the tumor microenvironment: host-related
features
Immunohistochemistry for anti-CD3, anti-CD8 and anti-
CD45RO highlights the T-lymphocytic immune reaction
in the microenvironment of the tumor within the tumor
center or invasion front across each tumor type
(Figure 3).
Discussion
The UICC/AJCC TNM classification is still regarded as
the gold standard for prognostication in colorectal
cancer. Nevertheless, TNM staging is recognized as
imperfect and is continuously updated. Consequently,
the need for new biomarkers is urgent. This has led to
an inundation of studies proposing novel and promising
prognostic factors. The lack of reproducibility and
standardization often leads to a rejection of such bio-
markers, perhaps prematurely in some cases. Over the
last 15 years, TMA technology has played a major role
in the translation of biomarkers into daily diagnostic
practice, but its use is often criticized as laborious,
imprecise and time-consuming; additionally, improper
planning on the strategic level decreases the strength of
TMA investigations further. Therefore, the simple
implementation of an automated TMA instrument can-
not be the definition of ngTMA. The construction of
ngTMA is a well-defined process including the following
steps (Figure 4):
Planning and design
Based on scientific hypothesis and requirements, an inter-
disciplinary research task force should consider statistical
issues such as sample size and the number of tissue
punches per patient depending on the tumor types and
especially from which tumor location. This step should be
considered the “strategic level” of ngTMA and should not
be under-estimated to avoid waste of time, material,
human and financial resources; fast scanning and user
friendly digital platform: these steps allow the visualization
of slides using a digital platform which is the interface
between all research groups involved and allows the discus-
sion of cases without the need for additional meetings that
are often logistically difficult to organize; precise annota-
tions: this step is likely the most crucial as it requires
experience in morphology to exactly determine the tumor
locations from which the tissue punches should be taken
from. In colorectal cancer, for example, a well-constructed
ngTMA should include punches from normal tissue, tumor
center, tumor front, intra-tumoral and peri-tumoral micro-
environment and if available preoperative biopsies, lymph
nodes or distant metastases. Differentiating these various
histological “zones” may be challenging to the untrained
eye and hence, an optimal ngTMA would be constructed
in collaboration with pathologists; automated punching:
this step facilitates the working process by its precision and
flexibility; the choice of the core size depends on the scien-
tific hypothesis; more “functional” ngTMAs such as one
investigating epithelial-mesenchymal transition (EMT) may
require a smaller sample size but larger tissue cores areas
(1.5-2.0 mm in diameter), whereas more high-throughput
studies could be performed using the “traditional” 0.6 mm
punch size. In our experience using a conventional arrayer,
an average of 15 cores can be punched and transferred per
hour. Donor block punching and transfer to the recipient
block took 12 seconds per core, thus significantly reducing
the time and human resources necessary for TMA
construction.
In the present analysis we tested whether the new
approach of “ngTMA” could be an ideal platform to
study the tumor microenvironment of different solid tu-
mors. Indeed, the selected immune markers CD3, CD8
and CD45RO which are proposed as important prognos-
tic immune infiltrates in the literature [8] could be
visualized by immunohistochemistry in precisely targe-
ted tissue punches from the microenvironment of the
tumor center and the tumor invasive front. This
approach may even become more important in the future
when not only proteins, but also mRNA and microRNA
can be visualized on paraffin embedded tissues using in
situ hybridization techniques.
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